EMVision Medical Devices (ASX:EMV) won AU$3 million in non-dilutive grant funding from the Australian government to study ways of improving stroke care through its emu brain scanners, according to a Friday filing with the Australian bourse.
The data from the study will be used to drive the adoption and commercialisation of the brain scanner, the filing said.